Correction to: Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study

Detalles Bibliográficos
Autores principales: Nakamura, Ichiro, Maegawa, Hiroshi, Tobe, Kazuyuki, Uno, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496576/
https://www.ncbi.nlm.nih.gov/pubmed/34279807
http://dx.doi.org/10.1007/s12325-021-01813-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496576/
https://www.ncbi.nlm.nih.gov/pubmed/34279807
http://dx.doi.org/10.1007/s12325-021-01813-8

Ejemplares similares